King Pharmaceuticals KG Percentage payout of incurred claims, year nine

Percentage payout of incurred claims, year nine at other companies

W.R. BerkleyWRB

4.6%-0.4pp

RenaissanceRe HoldingsRNR

1.3%+0.6pp

W.R. BerkleyWRB

4.7%+0.4pp

RenaissanceRe HoldingsRNR

3%+0.5pp

W.R. BerkleyWRB

3.4%+0.3pp

W.R. BerkleyWRB

7.4%+0.9pp

Segments

By product

See full

European Hospital Liability4.9%—

General Liability3.8%—

Commercial Auto Liability1.6%—

International-0.7%—

All other lines-0.4%—

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—